API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.globenewswire.com/news-release/2022/10/17/2535304/0/en/Mereo-BioPharma-Receives-FDA-Fast-Track-Designation-for-Alvelestat-for-Treatment-of-Alpha-1-Antitrypsin-Deficiency-AATD-associated-Lung-Disease.html
https://www.trialsitenews.com/p/trialsitenews/mereo-biopharmas-alvelestat-meets-endpoints-in-astraeus-trial-in-patients-with-alpha-1-antitrypsin-deficiency-associated-emphysema-a1c221e1
https://www.globenewswire.com/news-release/2020/08/25/2083126/0/en/Mereo-BioPharma-Announces-Initiation-of-Placebo-Controlled-Phase-1b-2-Clinical-Trial-with-Alvelestat-in-COVID-19-Respiratory-Disease.html
http://www.pmlive.com/pharma_news/celgene_says_no_to_mereos_cancer_drug_etigilimab_1291381